[Elsevier] LANCET - Orforglipron compared with dapagliflozin in adults with type 2 diabetes and inadequate glycaemic control with metformin (ACHIEVE-2): a multicentre, randomised, non-inferiority, open-label, phase 3 trial

Waltersport Post time Half hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-07-14 20:32
Reward10points

DOI: 10.1016/S0140-6736(26)00800-7
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    3535


Daily Top Contributors

Return to the list